Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

The Department of Health and Human Services says it will require new vaccines to be tested against a placebo, which could ...

Dr. Marty Makary had just finished his last surgery at Johns Hopkins when he stepped into one of the most powerful roles in ...

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine is sowing uncertainty about other ...

The U.S. government is putting down $500 million toward the development of a “universal” vaccine—a shot designed to protect ...

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

On May 1, the U.S. Department of Health and Human Services (HHS) and the National Institutes of Health (NIH) announced the ...

The U.S. Department of Health and Human services says it will require all new vaccines to be tested in placebo-controlled ...

Former intelligence office and Air Force Maj. Kacy Dixon tells her story about her separation from the military after defying ...

On a Thursday conference call with investors, Moderna CFO Jamey Mock outlined a roadmap for the mRNA specialist to lower its ...

Kennedy and FDA Commissioner Marty Makary’s approach to assessing vaccines could put Covid boosters out of reach.

Jefferies analysts said Moderna’s first quarter was “in line,” with a miss on revenue offset by a beat on earnings per share.